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Abstract
The effects of tamoxifen (TAM) were studied on the mitochondrial permeability transition (MPT) induced by the prooxidant
tert-butyl hydroperoxide (t-BuOOH) or the thiol cross-linker phenylarsine oxide (PhAsO), in the presence of Ca2+, in order to
clarify the mechanisms involved in the MPT inhibition by this drug. The combination of Ca2+ with t-BuOOH or PhAsO induces
mitochondrial swelling and depolarization of membrane potential (Ψ ). These events are inhibited by cyclosporine A (CyA),
suggesting the inhibition of the MPT. The pre-incubation of mitochondria with TAM also prevents those events and induces a
time-dependent reversal of Ψ depolarization following MPT induction, similarly to CyA. Moreover, TAM inhibits the Ca2+
release and the oxidation of NAD(P)H and protein thiol (–SH) groups promoted by t-BuOOH plus Ca2+. On the other hand,
the MPT induced by PhAsO plus Ca2+ does not induce –SH groups oxidation, supporting the notion that MPT induction by
this compound is not mediated by the oxidation of specific membrane proteins groups. However, TAM also inhibits the PhAsO
induced MPT, suggesting that this drug may inhibit this phenomenon by inhibiting PhAsO binding to –SH vicinal groups,
implicated in the MPT induction. These data indicate that the MPT inhibition by TAM may be related to its antioxidant capacity
in preventing the oxidation of NAD(P)H and –SH groups or by blocking these groups, since the oxidation of these groups increases
the sensitivity of mitochondria to the MPT induction. Additionally, they suggest an MPT-independent pathway for TAM-induced
apoptosis and a potential ER-independent mechanism for the effectiveness of this drug in the cancer therapy and prevention.
© 2004 Elsevier Ireland Ltd. All rights reserved.
Keywords: Mitochondrial permeability transition; NAD(P)H oxidation; Oxidative stress; Tamoxifen; Thiol groups oxidation
1. Introduction
Tamoxifen (TAM) has been successfully used
worldwide in the treatment of breast cancer as well as
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in the prevention of women with high susceptibility
to the disease [1–3]. Despite being an anti-estrogenic
drug, TAM also inhibits the growth of estrogen recep-
tor (ER)-negative breast cancer cells and other cell
types that lack the ER [4–6]. In fact, TAM has been
reported to have pro-apoptotic activity in many types
of ER-positive [7] and ER-negative tumor cells [8], as
well as ability to promote ER-dependent and indepen-
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dent programmed cell death [9,10]. Although many
studies have been performed, the mechanisms of an-
tiproliferative effects and pro-apoptotic action of TAM
remain controversial and not completely understood.
Mitochondria play a critical role in initiating both
apoptotic and necrotic cell death and many com-
pounds are known to induce programmed cell death
by pathways that involve mitochondria. A major
player is the mitochondrial permeability transition
(MPT) [11], characterized by depolarization of mi-
tochondrial membrane potential (Ψ ), Ca2+ release,
mitochondrial swelling and rupture of mitochondrial
membrane, leading to the release of cytochrome c and
other pro-apoptotic molecules, which then activate
the caspase cascade that sets apoptosis in motion [12].
TAM is a lipophilic antioxidant with high partitioning
into membranes [13] and it has been shown to inhibit
the MPT induced in vitro by inorganic phosphate (Pi)
and Ca2+ [14]. Ca2+-induced MPT can be stimulated
by a wide variety of compounds with different chem-
ical characteristics, including Pi, oxidizing agents,
dithiol reagents, protonophores and ligands of the
adenine nucleotide translocator (ANT) [15]. This phe-
nomenon is accompanied by oxidative stress which
in turn induces oxidation of mitochondrial membrane
protein thiol (–SH) groups, matrix GSH and depletion
of pyridine nucleotides [NAD(P)H] [16–18].
TAM is an efficient inhibitor of lipid peroxidation
induced by Fe2+/ascorbate and a strong intramembra-
neous scavenger of peroxyl radicals [19]. Owing to its
antioxidant properties, TAM [19,20] is a potential in-
hibitor of the MPT stimulated by prooxidants. There-
fore, the aim of this study was to evaluate the effects
of TAM on the MPT induced by prooxidants such as
tert-butylhydroperoxide (t-BuOOH) [21] and by the
thiol cross-linker phenylarsine oxide (PhAsO) [18,22]
in the presence of Ca2+, contributing to clarify the
molecular mechanisms of TAM-induced MPT inhibi-
tion and to better elucidate the signalling pathway for
the controversial apoptotic effects of this drug.
2. Materials and methods
2.1. Chemicals
Tamoxifen (TAM), 4-(2-hydroxymethyl)-1-piperaz-
ineethanesulfonic acid (HEPES), bovine serum al-
bumin (BSA), cyclosporine A (CyA), oligomycin,
5,5′-dithiobis(2-nitro-benzoic acid) (DTNB), ethylene-
diaminetetraacetic acid (EDTA), ethylene glycol-bis(-
aminoethylether) NNN′N′-tetraacetic acid (EGTA),
phenylarsine oxide (PhAsO) and tert-butyl hydroper-
oxide (t-BuOOH) were purchased from Sigma Chem-
ical Co. (St. Louis, MO). Tetraphenylphosphonium
(TPP+) and sucrose were from MercK (Darmstadt,
Germany). All the chemicals were commercial prod-
ucts of the highest purity grade available.
2.2. Isolation of rat liver mitochondria
Mitochondria were isolated from the liver of fasted
overnight rats of either sex (Wistar) by conventional
differential centrifugation techniques as described
elsewhere [23] with slight modifications. Animals
were killed by cervical dislocation and the liver was
immediately excised and cooled at 4 ◦C in isolation
medium containing 2250 mannitol, 75 mM sucrose,
10 mM HEPES (pH 7.4), 1 mM EGTA and 0.1%
BSA free fatty acid, which was added just prior to
use. The cooled liver was then minced with scissors
and washed in isolation medium, then diluted and
homogenised with same medium and centrifuged at
1200 × g for 10 min. The mitochondrial pellet was
re-suspended in the washing medium, adjusted to pH
7.2 in the absence of either EGTA and BSA, and
mitochondria washed twice were recovered from the
supernatant at 10,000 × g for 10 min. Mitochondrial
protein was measured by the method of biuret [24]
with BSA as protein standard.
2.3. Standard incubation procedure
The experiments were carried out at 30 ◦C in a
standard reaction medium containing 200 mM su-
crose, 10 mM Tris-Mops (pH 7.4), 1 mM KH2PO4
and 10M EGTA, supplemented with 2M rotenone
and 0.5g oligomycin/ml as described elsewhere
[14]. Mitochondria were pre-incubated with t-BuOOH
(50M) or PhAsO (2M) before Ca2+ addi-
tion. TAM (20 nmol/mg protein) or CyA (0.85M)
were added from stock ethanolic solutions and
pre-incubated with mitochondria for 3 min before
succinate addition to start the reaction or after mi-
tochondrial loading with Ca2+, as indicated in the
figure legends. The results shown represent typical
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recordings from experiments of at least three different
mitochondrial preparations.
2.4. Mitochondrial swelling
Changes in mitochondrial osmotic volume were
monitored by the decrease in apparent absorbance
(light-scattering) at 540 nm, with a Perkin Elmer
Lambda 6 UV-Vis spectrophotometer computer con-
trolled (Norwalk, USA), as described previously [25].
Mitochondria (0.5 mg protein/ml) were suspended in
2 ml of standard reaction medium at 30 ◦C supple-
mented with t-BuOOH (50M) or PhAsO (2M)
and the reaction was started with 5 mM succinate.
CaCl2 (50 nmol/mg protein) was added 2 min after
energization of mitochondria with succinate.
2.5. Mitochondrial membrane potential
measurements
The mitochondrial membrane potential (Ψ ) was
monitored by evaluating transmembrane distribu-
tion of tetraphenylphosphonium (TPP+) with an
ion-selective electrode prepared according to Kamo
et al. [26] using a Ag/AgCl2 electrode as reference
(model MI 402; Microelectrodes, Inc., Bedford, NH).
Reactions were carried out in an open vessel with
magnetic stirring in 2 ml of standard reaction medium
supplemented with 4M TPP+. The standard reaction
medium was supplemented with t-BuOOH (50M)
or PhAsO (2M) and the reaction was started with
5 mM succinate and CaCl2 (50 nmol/mg protein) was
added after steady-state distribution of TPP+. Ψ
was estimated from the decrease of TPP+ concentra-
tion in the medium as described elsewhere [26,27].
2.6. Mitochondrial Ca2+ fluxes
Mitochondrial Ca2+ fluxes were measured by
monitoring the changes in Ca2+ concentration in the
reaction medium using a Ca2+-sensitive electrode,
according to previously described procedures [23,28].
Reactions were carried out in an open vessel with
magnetic stirring in 2 ml of standard reaction medium
supplemented with CaCl2 (50 nmol/mg protein) and
started by adding 5 mM succinate to mitochondrial
suspensions (0.5 mg protein/ml) pre-incubated with
t-BuOOH (50M).
2.7. Determination of NAD(P)H redox state
The redox state of pyridine nucleotides in mito-
chondria was followed fluorometrically at 366 nm
excitation (slit 3 nm) and 450 nm emission (slit 5 nm)
wavelengths in a Perkin Elmer spectrofluorometer
LS-50 B [29]. Mitochondria (0.5 mg protein/ml) were
suspended in 2 ml of standard reaction medium with
t-BuOOH (50M) and the reaction was started with
5 mM succinate. CaCl2 (50 nmol/mg protein) was
added 2 min after energization of mitochondria. At
the end of an experiment the auto-fluorescence of
the reduced pyridine nucleotides was observed un-
der conditions allowing the reduction of inner mi-
tochondrial pyridine nucleotides. This was achieved
by supplementation of reducing respiratory sub-
strates (RS) 5 mM -hydroxybutyrate and 0.1 mM
isocitrate.
2.8. Determination of protein thiol content
Protein thiol groups were measured by the method
of Monte et al. [30], with little modification. Mito-
chondrial suspensions (1 mg protein/2 ml) was added
to 0.5 ml of 0.5% (w/v) trichloroacetic acid and the
protein sedimented by centrifugation at 3200 × g for
12 min (KUBOTA 5400). The supernatant was dis-
carded and the pellet was suspended in 2 ml phosphate
buffer (20 mM Na2HPO4, 110 mM NaCl and 1 mM
EDTA, pH 7.4). To 0.5 ml of this suspension it was
added 4.5 ml of phosphate buffer and a 50l aliquot of
10 mM 5,5′-dithiobis(2-nitro-benzoic acid) (Ellman’s
reagent or DTNB) in methanol was then added and
mixed well. The absorbance was measured at 412 nm
within 15 min.
2.9. Statistical analysis
The percentage of oxidized –SH groups in each ex-
periment was determined relatively to the experiment
with Ca2+ alone (control) (100%). The results are pre-
sented as mean ± S.D. of at least three independent
experiments. Comparisons between the different as-
says were made using the one-way analysis of vari-
ance (ANOVA) followed by the Tukey post-test, for
multiple comparisons. A P value <0.05 was consid-
ered statistically significant.
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3. Results
To clarify the mechanisms by which TAM inhibits
the MPT, mitochondria were treated with t-BuOOH
(50M) (Fig. 1A) and energized with succinate in
the presence of Ca2+ (50 nmol/mg protein) (Ca2+
+ t-BuOOH). As observed at 540 nm, mitochondria
undergo a rapid and large decrease in the absorbance
(Ca2+ + t-BuOOH), suggesting complete swelling
of mitochondria (Fig. 1A). This extensive effect is
completely prevented by pre-incubating mitochondria
with 20 nmol TAM/mg protein (TAM), as reported
previously to OHTAM [23]. Such effects are similar
to those observed with cyclosporine A (0.85M)
(Fig. 1A—CyA), a specific and potent inhibitor of
the MPT [31], suggesting that TAM completely
protects against the Ca2+−t-BuOOH-induced MPT
(Fig. 1A—TAM). This concentration of TAM does
not significantly affect the Ψ and phosphorylation
efficiency of mitochondria, as previously reported
[32]. However, higher concentrations of TAM induce
destructive effects in the structural integrity of the
mitochondrial membrane [32]. When added alone,
neither Ca2+ (Fig. 1A—Ca2+ alone) nor t-BuOOH
(Fig. 1A—t-BuOOH alone) induce any significant
decrease in absorbance, indicating that none of them
is able by itself to induce mitochondrial swelling
in the used concentrations. PhAsO (2M), a thiol
cross-linking agent, was also used in combination
with Ca2+ (50 nmol/mg protein) to induce the MPT
(Fig. 1B). Similar to that observed with mitochon-
dria pre-incubated with Ca2+ (Fig. 1B—Ca2+ alone),
PhAsO alone is not able to change the absorbance
of mitochondrial suspensions measured at 540 nm.
However, mitochondria incubated in the presence
of Ca2+ plus PhAsO undergo a strong decrease
in absorbance at 540 nm, indicative of mitochon-
drial swelling (Fig. 1B—Ca2+ + PhAsO). Similar
to CyA (Fig. 1B—CyA), pre-incubation with TAM
(20 nmol/mg protein) prevents the occurrence of this
effect owing to the inhibition of the MPT induction
(Fig. 1B—TAM).
The inhibitory effects of TAM on the induction of
the MPT by Ca2+ plus t-BuOOH are also demon-
strated by the fact this drug prevents the Ca2+-induced
depolarization of Ψ associated with MPT induction
(Fig. 2A). The addition of Ca2+ (50 nmol/mg protein)
(Fig. 2A—Ca2+ alone) causes a transient depolar-
Fig. 1. TAM protects the mitochondrial swelling induced by
either t-BuOOH (A) or PhAsO (B). Rat liver mitochon-
dria (0.5 mg protein/ml) in 2 ml of standard reaction medium
supplemented with 2M rotenone and 0.5g/ml oligomycin,
were energized with 5 mM succinate at 30 ◦C. Mitochondrial
swelling was induced with 50M t-BuOOH (A) or 2M
PhAsO (B) pre-incubated with mitochondria in the presence
of Ca2+ (50 nmol/mg protein) as labelled, respectively, by Ca2+
+ t-BuOOH or Ca2+ + PhAsO. Mitochondria were pre-incubated
with TAM (20 nmol/mg protein) or CyA (0.85M) for 3 min be-
fore succinate addition. Mitochondria were also treated with Ca2+
alone, with t-BuOOH or with PhAsO alone, as indicated in the
figures. The mitochondrial swelling was followed continuously at
540 nm and the traces, labelled by the names, are typical of three
experiments with different mitochondrial preparations.
ization, Ψ returning to near 205 mV within 2 min.
However, in mitochondria treated with t-BuOOH, the
repolarization of Ψ after Ca2+ accumulation is fol-
lowed by a dramatic and irreversible depolarization
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Fig. 2. TAM prevents the mitochondrial depolarization associated with MPT induction. Mitochondria (1 mg) were incubated in the standard
reaction medium supplemented with 2M rotenone, 0.5g/ml oligomycin and 4M TPP+ at 30 ◦C. The reactions were started with 5 mM
succinate and Ca2+ (50 nmol/mg protein) was added after steady state distribution of TPP+. Mitochondria were supplemented with Ca2+
after pre-incubation either 50M t-BuOOH (Ca2+ + t-BuOOH) (A) or 2M PhAsO (Ca2+ + PhAsO) (B). TAM (20 nmol/mg protein) or
CyA (0.85M) were added to mitochondria 3 min prior to adding t-BuOOH (A) or PhAsO (B). Either Ca2+, t-BuOOH or PhAsO alone
were also added to mitochondrial suspensions (traces labelled by the respective names). CyA and Ca2+ alone traces are coincident (B).
The traces are typical of experiments with three different mitochondrial preparations.
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of mitochondria over the course of the next 10 min
(Fig. 2A—Ca2+ + t-BuOOH). Pre-incubation of mi-
tochondria with TAM in the presence of t-BuOOH,
prior to adding succinate and Ca2+, affords protection
against the Ca2+-induced irreversible depolarization
of Ψ , similarly to CyA (Fig. 2A—TAM, CyA). Un-
der these conditions, the Ca2+ uptake causes a tran-
sient depolarization of Ψ but mitochondria are able
to develop and sustain the Ψ . Treating mitochondria
with Ca2+ in the absence of t-BuOOH (Fig. 2A—Ca2+
alone) or with t-BuOOH alone (Fig. 2A—t-BuOOH
alone) does not induce mitochondrial depolarization.
The effects of TAM were also investigated on the
depolarization of Ψ induced by the combination of
Ca2+ plus PhAsO (Fig. 2B). As observed with the
t-BuOOH experiments (Fig. 2A), neither Ca2+ alone
(Fig. 2B—Ca2+ alone) nor PhAsO (Fig. 2B—PhAsO
alone) is able to cause Ψ depolarization, con-
trarily to that observed with mitochondria treated
with PhAsO plus Ca2+ (Fig. 2B—Ca2+ + PhAsO).
Pre-incubation of mitochondrial suspensions with
TAM prevents from the PhAsO plus Ca2+-induced
depolarization (Fig. 2B—TAM). Moreover, the addi-
tion of TAM to mitochondrial suspensions undergo-
ing Ψ depolarization promoted by either t-BuOOH
(Fig. 3A) or PhAsO (Fig. 3B) plus Ca2+ induces
repolarization of Ψ and the capacity of mitochon-
dria to sustain the Ψ developed in a similar way to
CyA, indicating that this antiestrogen has the ability
to prevent and revert the MPT induction promoted by
prooxidants and thiol cross-linkers. However, TAM at
20 nmol/mg protein added after Ca2+-induced MPT
only partially promotes repolarization of Ψ as com-
pared to CyA (Fig. 3A and B) since TAM, according
to our previous reports [14,32] induces proton leak
through the mitochondrial inner membrane.
Further evidence that TAM inhibits the Ca2+ plus
t-BuOOH-induced MPT is provided by the fact that
this drug prevents the release of mitochondrial loaded
Ca2+ (Fig. 4). In fact, mitochondria pre-incubated with
t-BuOOH and energized with succinate release the ac-
cumulated Ca2+ within about 15 min (Fig. 4A—Ca2+
+ t-BuOOH). However, TAM affords to mitochondria
capacity to accumulate and sustain the added Ca2+
similarly to that observed with CyA. Moreover, TAM
added during the time course of the Ca2+ release, re-
lated to MPT promoted by Ca2+ plus t-BuOOH, in-
duces re-uptake of the released Ca2+ by mitochondria
(Fig. 4B), in agreement with the repolarization effect
referred above (Fig. 3A). However, these effects are
also dependent on the time elapsed after Ca2+ addi-
tion. CyA, even when added late in the reaction, causes
total re-uptake of the released Ca2+ (Fig. 4B).
The oxidation of mitochondrial pyridine nucleotides
[NAD(P)H] also characterizes the induction of the
MPT. Therefore, the changes in the oxidized/reduced
state of pyridine nucleotides were also followed by
monitoring the fluorescence intensity of mitochon-
drial suspensions treated with t-BuOOH in the pres-
ence of Ca2+ (Fig. 5). The fluorescence of reduced
pyridine nucleotides (NADH and NADPH) accounts
for most of the cellular auto-fluorescence excited
with near UV light, however oxidized pyridine nu-
cleotides (NAD+ and NADP+) are non-fluorescent.
Accordingly, changes in auto-fluorescence reflect
changes in the redox state of pyridine nucleotides.
During the time course of the MPT induced by Ca2+
plus t-BuOOH (Fig. 5—Ca2+ + t-BuOOH) there is
hydrolysis and/or oxidation of NAD(P)H after Ca2+
addition to t-BuOOH pre-incubated mitochondria, as
there is a decline in mitochondrial auto-fluorescence.
Pre-incubation of mitochondria with TAM prevents
the decrease in NAD(P)H content, as it maintains
the auto-fluorescence intensity unchanged, similarly
to pre-incubation with CyA. Mitochondrial suspen-
sions pre-incubated with Ca2+ (Fig. 5—Ca2+ alone)
or t-BuOOH alone (Fig. 5—t-BuOOH alone) do not
undergo any alteration in auto-fluorescence intensity,
which is in accordance with that observed in ex-
periments of mitochondrial swelling (Fig. 1A), Ψ
depolarization (Fig. 2A) and Ca2+ release (Fig. 4A).
Considering that the oxidation state of cysteine
residues has been proposed as a critical factor reg-
ulating the induction of the MPT [33], the thiol
groups content of mitochondria treated with Ca2+ and
t-BuOOH (Fig. 6A—Ca2+ + t-BuOOH) or PhAsO
(Fig. 6B—Ca2+ + PhAsO) was also determined.
The amount of Ca2+ used, per se, does not induce
the MPT. Therefore, the percentage of oxidized –SH
groups in each experiment was determined relatively
to the experiment with Ca2+ alone (control), that
was considered as 100% of –SH in the reduced state.
t-BuOOH alone is not able to induce significant –SH
groups oxidation relatively to the experiment with
Ca2+ plus t-BuOOH. TAM (Fig. 6A—TAM) prevents
the oxidation of –SH groups induced by Ca2+ plus
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Fig. 3. TAM reverses Ψ depolarization due to MPT induction by Ca2+ (50 nmol/mg protein) plus 50M t-BuOOH (A) or 2M PhAsO (B).
The reactions were carried out as described for Fig. 2 except that TAM (20 nmol/mg protein) was added at different times after Ca2+-induced
depolarization and CyA added later, as indicated by the corresponding labelled arrows. Mitochondrial depolarization and repolarization
were monitored by following Ψ with a TPP+-selective electrode. All the traces are representative of three separate experiments.
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Fig. 5. Effects of TAM on the redox state of pyridine nucleotides during MPT induction as measured fluorometrically (366/450 nm). Rat
liver mitochondria (0.5 mg protein/ml) were incubated in 2 ml of standard reaction medium supplemented with 2M rotenone, 0.5g/ml
oligomycin and energized with 5 mM succinate, at 30 ◦C, before Ca2+ (50 nmol/mg protein) addition. The MPT was induced by 50M
t-BuOOH, pre-incubated with mitochondria, in the presence of Ca2+ (Ca2+ + t-BuOOH). Mitochondria were also pre-incubated with TAM
(20 nmol/mg protein) or CyA (0.85M) for 3 min before succinate addition. Either Ca2+ or t-BuOOH alone was also added to mitochondrial
suspensions, as indicated in the figure. All the traces, labelled by the respective names, are representative of three separate experiments. The
supplementation of reducing respiratory substrates (RS) (5 mM -hydroxybutyrate and 0.1 mM isocitrate) for the re-reduction of pyridine
nucleotides [NAD(P)H Red] was as indicated by the arrow.
t-BuOOH. Pre-incubation of mitochondria with CyA
also affords protection against –SH groups oxidation
(Fig. 6A—CyA), though the effects of TAM are more
significant than those of CyA. In the case of induction
of the MPT with Ca2+ plus PhAsO there is no observ-
able oxidation of –SH groups (Fig. 6B), suggesting
that this event is not involved in the MPT induction
with this compound. Instead, it reversibly forms a
five membered ring with vicinal thiols, inducing thiol
cross-linkage and promoting the Ca2+-dependent in-
tramitochondrial NAD+-hydrolysis [34]. Since CyA
inhibits the MPT even when crucial thiols are oxi-
dized, the prevention induced by TAM may be related
to its high affinity to bind to membrane proteins, thus
Fig. 4. The inhibitory effects of TAM on mitochondrial Ca2+ release related to the MPT induction. Mitochondria (1 mg) were suspended
in 2 ml of standard reaction medium supplemented with 2M rotenone and 0.5g/ml oligomycin at 30 ◦C and the reactions were started
with 5 mM succinate. Mitochondria were treated with 50M t-BuOOH in the presence of Ca2+ (50 nmol/mg protein) to induce MPT
(Ca2+ + t-BuOOH). TAM (20 nmol/mg protein) or CyA (0.85M) were added to mitochondria 3 min prior to adding t-BuOOH (A) or at
different times during the course of MPT (B). Mitochondria were also treated with Ca2+ or t-BuOOH alone, as indicated in the figures.
The uptake and release of sequestered Ca2+ by mitochondria were monitored by using a Ca2+-selective electrode and the traces are typical
of three experiments with different mitochondrial preparations.
blocking the interaction of PhAsO with protein thiol
groups components of the MPT.
4. Discussion
In this study an attempt has been made to eluci-
date the mechanism(s) underlying TAM inhibition of
the MPT in isolated rat liver mitochondria. In fact,
TAM was able to prevent the mitochondrial swelling
promoted by Ca2+ plus either t-BuOOH (Fig. 1A) or
PhAsO (Fig. 1B) and to inhibit theΨ depolarization
associated with MPT induction by these different in-
ducers (Fig. 2A and B). Moreover, TAM also induces
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Fig. 6. Effects of TAM on mitochondrial thiol groups oxida-
tion related with MPT induction. Rat liver mitochondria, at
1 mg protein/2 ml of standard reaction medium supplemented with
2M rotenone and 0.5g/ml oligomycin, were pre-incubated
with either 50M t-BuOOH (A), 2M PhAsO (B) after Ca2+
(50 nmol/mg protein) uptake and energized with 5 mM succi-
nate at 30 ◦C. Mitochondria were also pre-incubated with TAM
(20 nmol/mg protein) or CyA (0.85M) for 3 min prior to starting
the reactions and treated with t-BuOOH, PhAsO or with Ca2+
alone, as indicated in the figures. Thiol groups were evaluated
by the Ellman’s reagent. Values are expressed as percentage of
the thiol groups of mitochondria treated with Ca2+ alone (100%)
(control) and represent the average of 3–5 experiments ± S.D. Sta-
tistical significance: ∗: P < 0.05, ∗∗: P < 0.01 as compared to the
experiment with Ca2+ + t-BuOOH (A) or with Ca2+ + PhAsO
(B).
repolarization after MPT induction by the combina-
tions of Ca2+ with the prooxidant t-BuOOH (Fig. 3A)
or with the thiol cross-linker PhAsO (Fig. 3B). TAM
also exhibited its inhibitory effects against the mito-
chondrial Ca2+ release related to the MPT induction
and induced Ca2+ re-uptake by mitochondria after
the onset of MPT with Ca2+ plus t-BuOOH (Fig. 4).
As the MPT induction is associated with oxidation
of either pyridine nucleotides [NAD(P)H] or criti-
cal thiol groups, possibly located in the ANT [18],
the effect of TAM on such oxidative reactions was
also investigated. The MPT induction with t-BuOOH
plus Ca2+ was associated with NAD(P)H oxidation
as demonstrated by the decrease in fluorescence in-
tensity of mitochondria pre-incubated with t-BuOOH
after Ca2+ addition (Fig. 5). A similar behaviour was
observed when mitochondria were pre-incubated with
PhAsO, instead of t-BuOOH, e.g., the addition of
Ca2+ to mitochondria caused the MPT and resulted
in a rapid and extensive pyridine nucleotide oxida-
tion (results not shown). In addition to the oxidation
of –SH groups and pyridine nucleotides [NAD(P)H],
the generation of ROS within mitochondria (or a
decreasing in their detoxification) contributes to the
induction of the MPT, as shown by studies with sev-
eral MPT inducers [35–37]. Different studies from
several laboratories have demonstrated that the MPT
induced by prooxidants as t-BuOOH is triggered by
Ca2+-stimulated production of ROS, which accumu-
late due to exhaustion of the mitochondrial antioxi-
dants GSH and NAD(P)H [38–40]. The attack of ROS
to membrane protein thiols produces cross-linkage
reactions and opening of membrane pores upon Ca2+
binding. In fact, it has already been shown that mito-
chondrial protein complexes that participate in critical
mitochondrial/cellular processes, such as the MPT,
contain inner mitochondrial membrane proteins with
critical thiols that can be readily oxidized leading to
the onset of MPT [37,41,42]. Therefore, concerning to
thiol groups oxidation, when the MPT was promoted
with Ca2+ plus t-BuOOH (Fig. 6A) there is oxidation
of –SH groups that is inhibited by pre-incubation of
mitochondria with TAM. In contrast, when the MPT
was promoted with PhAsO plus Ca2+ we do not ob-
serve –SH groups oxidation (Fig. 6B), probably due
to the ability of PhAsO to induce MPT through thiol
cross-linkage of vicinal thiols. According to some
authors [39,40], the mitochondrial permeabilization
induced by thiol cross-linkers, such as PhAsO, is in-
dependent of ROS and a consequence of cross-linkage
promoted directly by this compound, although Nov-
gorodov et al. [43] claimed to a certain relationship
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between the cross-linking of two juxtaposed thiol
groups and the free radical process in mitochondria.
PhAsO has been shown to exert its effect by attacking
vicinal thiols on proteins [44] and seems to be able
to attack directly the pore components: it reversibly
forms a five membered ring with vicinal thiols and
promotes the Ca2+ dependent intramitochondrial
NAD+ hydrolysis [34,45].
The reversible permeabilization of the inner mito-
chondrial membrane induced by Ca2+ in the pres-
ence of prooxidants is under the regulatory influence
of the redox status of both mitochondrial pyridine
nucleotides and membrane protein thiols-forming
cross-linked protein aggregates [18,46,47], in which
Ca2+ and prooxidants play a concerted role in ROS
accumulation within the mitochondria [36,48]. In
fact, the prooxidant and the thiol cross-linker per se
were unable to cause mitochondrial swelling (Fig. 1),
depolarization of Ψ (Fig. 2), oxidation of NAD(P)H
(Fig. 5) or of thiol groups (Fig. 6), suggesting that
Ca2+ is essential and must act in additional steps in
the sequence of events that lead to mitochondrial per-
meabilization [38,41]. Therefore, the inhibition of the
MPT by TAM seems to be dependent on its antiox-
idant/scavenging activities [19], protecting against
pyridine nucleotides and –SH groups oxidation.
On the other hand, since TAM incorporates to a
greater extent into native membranes relatively to the
respective lipid dispersions [13], as it binds to proteins
in a non specific manner [49], it is probable that in ad-
dition the its antioxidant mechanism TAM may bind
to the mitochondrial cyclophylin D, a necessary com-
ponent for the MPT pore, inhibiting the pore assem-
bly, in a similar way to what was described for CyA
[15]. Moreover, since TAM also inhibits the MPT in-
duced by PhAsO, this antiestrogen may act by bind-
ing to the –SH sites of the ANT, a central component
of the MPT pore, protecting thiol cross-linking or ox-
idation of these critical groups in the MPT induction.
Therefore, the MPT inhibition by TAM may depend
on different effects of this drug at the mitochondrial
level.
Although TAM and its metabolite, OHTAM, in-
hibit the Ca2+-prooxidant or the Ca2+-Pi-induced
MPT [14,23], they exhibit different apoptotic effects
[50] in human mammary epithelial cells which may
be related to the slightly effects of OHTAM on the
mitochondrial bioenergetic functions [51], in contrast
with the deleterious effects of TAM as evaluated in
rat liver mitochondria [32]. Until recently, the main
function of mitochondria was thought to be limited to
the production of energy in the form of ATP. How-
ever, in a few years a new role for this organelle has
emerged. It is now well established that mitochondria
play a critical role in the regulation of apoptosis by
acting as reservoirs for a multitude of apoptogenic
proteins [52]. Most of the mechanisms of necrosis
and apoptosis appear to include the MPT that leads
to the disruption of the outer membrane and release
of apoptotic factors from the intermembrane space
[11].
Moreover, this work also demonstrates that TAM
inhibits the CyA-sensitive MPT induced by the com-
bination of Ca2+ with different inducers and also sug-
gests an MPT-independent pathway for TAM-induced
apoptosis and describes an activity distinct from their
ER-dependent ability that may lead to necrotic cell
death as an additional mechanism for the effectiveness
of TAM in cancer therapy and chemoprevention.
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